Replimune Group (NASDAQ:REPL) Insider Christopher Sarchi Sells 6,500 Shares

robot
Abstract generation in progress

Replimune Group (NASDAQ:REPL) insider Christopher Sarchi sold 6,500 shares of the company’s stock on April 2nd at an average price of $8.01, totaling $52,065. This transaction reduced his ownership by 4.11% to 151,588 shares and was conducted under a pre-arranged Rule 10b5-1 trading plan. The company, a clinical-stage biotech focused on oncolytic immunotherapies, currently has a consensus “Hold” rating from analysts with an average target price of $10.00.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin